A featured contribution from Insights: a curated forum reserved for leaders nominated by our subscribers and vetted by our Medical Care Review Advisory Board.
Irsfeld Pharmacy
Steve Irsfeld, RPh, Owner
How Low-Dose Naltrexone is Changing Chronic Pain Care

Steve Irsfeld, RPh
Pharmacy Practice LeaderLow-dose naltrexone, or LDN, has become a big part of our practice at Irsfeld Pharmacy over the last 20 years. In those first ten years, however, we really didn't know a whole lot about what the medication did because there was very little research available.
Our Pharmacy, which is located in Dickinson, ND, works closely with many providers on complex pain cases. One pain specialist that specifically comes to mind, always embraced the ideas my staff and I present regarding compounding and dietary supplements for pain management. I had just returned from a conference in Chicago, where one of the speakers discussed LDN and its potential to benefit many patients, especially those with chronic pain. When I got back to the pharmacy, I reached out to this pain management provider to share what I had learned. She stopped me and said she had also attended a conference where LDN was the topic of discussion. That was really the beginning of a period of growth for our LDN practice. We became very busy with new prescriptions and counseling patients on LDN, but something didn't add up. Our numbers didn't reflect the amount of work we were doing.We were losing patients, but we didn't know why.
Around that same time, I listened to a podcast about customer relationship management software and how it could improve communication with patients. After hearing the podcast, I immediately knew we needed a system like that. We implemented the CRM in 2021, but because we were busy in other areas of the pharmacy, we didn't use it to its full potential. In 2022, we made a commitment to fully embrace the software. It transformed the way we followed up with patients, allowing our team to stay in better contact, monitor progress and provide the encouragement many patients needed while taking LDN.
"If I could offer one piece of advice to anyone starting LDN for chronic pain, it would be this: be patient. Give the medication six to nine months before deciding it isn't working. Many patients don't experience immediate relief, but those who stay the course are often rewarded with meaningful improvements over time."
LDN is unlike any other medication we use for pain management because it works through several different mechanisms. It helps increase the body's natural endorphins, which stimulate opioid receptors. It also blocks toll-like receptors, which can increase inflammatory mediators, and specifically blocks TLR-4, a receptor involved in neuroinflammation. Each of these mechanisms targets a different aspect of chronic pain, making LDN a unique option for many patients.
For patients with fibromyalgia, a condition involving pain, inflammation and neuroinflammation, I feel we get especially good results because LDN addresses all three of these mechanisms.
A large part of our counseling and follow-up involves adjusting doses, encouraging patients to hang in there and simply being a cheerleader for people who have been suffering from chronic pain for a long time. LDN is an amazing medication, and when given the time it deserves, it can become an effective alternative to many traditional pain medications for chronic pain.
Low-dose naltrexone is one of the safest and most affordable medications we compound for chronic pain. If you've been searching for relief without success, wouldn't it be worth asking if LDN is an option for you? While it's not right for everyone, LDN has helped many patients improve their quality of life with a personalized approach and a little patience.
Until next time, be vigilant about your health!